Global Pulmonary Drug Delivery Systems Market By Product Type (Dry Powder Inhaler (Single-dose Inhaler and Multi-dose Inhaler), Metered Dose Inhaler (Manually-actuated Pressurized Inhaler and Breath-actuated Pressurized Inhaler), Nebulizer (Jet Nebulizer, Ultrasonic Wave Nebulizer, and Vibrating Mesh Nebulizer), and Accessories), By Application (Cystic Fibrosis, Asthma, Allergic Rhinitis, COPD, and Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and E-Commerce), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Aug 2024
- Report ID: 127061
- Number of Pages: 367
- Format:
-
-
-
- Teva Pharmaceutical Industries Ltd. Company Profile
- RIGImmune
- Philips Respironics
- PARI GmbH
- Omron Healthcare, Inc.
- GlaxoSmithKline PLC
- Gilbert Technologies
- Hoffmann-La Roche AG
- Boehringer Ingelheim GmbH
- Aptar Pharma
- AstraZeneca Plc Company Profile
- 3M Healthcare
- settingsSettings
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
---|---|---|---|
e-Access | |||
Report Library Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |